New medicines : the practice of medicine, and public policy, a strategic view of how innovation in the development of medicines will impact on the practice of medicine and the delivery of healthcare during the next two decades

This essay - by the chairman of Glaxo Wellcome Plc - takes a strategic view of how innovation in the development of medicines will impact on the practice of medicine and the delivery of healthcare in the first two decades of the 21st century.

It opens with a brief review of the impact of modern medicines on society and goes on to describe some of the new processes that are transforming the processes of medicines and what this will mean for the biopharmaceutical industry, and consequently medical practice.

A vision of how medical practice could develop and policy issues related to this are discussed in further chapters.

The emphasis in the book is on global developments and global issues using country-specific examples only when necessary.

A broad industry perspective is also taken.